文献速递衰弱、肌少症与跌倒老年慢病共病管理

低瘦体重伴与不伴肥胖及死亡率:1999-2004年美国国家健康与营养调查结果

Low Lean Mass With and Without Obesity, and Mortality: Results From the 1999-2004 National Health and Nutrition Examination Survey.
PubMed 文献 · J Gerontol A Biol Sci Med Sci · 2017-01-01

该研究基于1999-2004年美国国家健康与营养调查中4984名60岁及以上人群,随访中位102个月,发现低瘦体重者死亡风险高于低瘦体重伴肥胖者,男性风险升高更明显;高龄、糖尿病、卒中、心衰、癌症和肾病可预测死亡。

要点

  • 低瘦体重男性死亡风险HR为1.49(1.27, 1.73),女性为1.19(1.02, 1.40)。
  • 低瘦体重伴肥胖男性死亡风险HR为1.31(1.11, 1.55),女性为0.99(0.85, 1.16)。
  • 高龄、糖尿病、卒中、心衰、癌症和肾病可预测两类人群死亡预后更差。

核心结论

  • 低瘦体重者死亡风险高于低瘦体重伴肥胖者。
  • 高龄、糖尿病、卒中、心衰、癌症和肾病可预测两类分类下更差预后。

研究设计与样本

  • 从1999-2004年美国国家健康与营养调查中识别4984名60岁及以上受试者,并链接国家死亡索引。
  • 低瘦体重定义为四肢瘦体重降低(男性<19.75 kg;女性<15.02 kg),肥胖定义为双能X线吸收法体脂(男性≥25%;女性≥35%)。
  • 采用比例风险模型分别确定低瘦体重及低瘦体重伴肥胖的死亡风险,参照组分别为无低瘦体重和无低瘦体重伴肥胖。

主要发现

  • 平均年龄71.1±0.19岁,女性占56.5%。
  • 中位随访102个月(四分位距:78,124),死亡1901例(35.0%)。
  • 低瘦体重伴肥胖的患病率女性为33.5%,男性为12.6%。
  • 低瘦体重者总死亡风险男性为1.49(1.27, 1.73),女性为1.19(1.02, 1.40)。
  • 低瘦体重伴肥胖者死亡风险男性为1.31(1.11, 1.55),女性为0.99(0.85, 1.16)。

关键数值与推荐

  • 低瘦体重截点:男性四肢瘦体重<19.75 kg,女性<15.02 kg。
  • 肥胖截点:男性体脂≥25%,女性体脂≥35%。
  • 低瘦体重伴肥胖需同时满足低瘦体重和肥胖标准。

临床怎么用

  • 对60岁及以上老年人可依据四肢瘦体重和体脂评估低瘦体重及低瘦体重伴肥胖。
  • 低瘦体重男性死亡风险升高更明显,女性低瘦体重伴肥胖未显示死亡风险升高。
  • 高龄、糖尿病、卒中、心衰、癌症和肾病患者在两类分类下均应关注更差预后。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The Foundation for the NIH Sarcopenia Project validated cutpoints for appendicular lean mass. We ascertained the relationship between low lean mass (LLM), obesity, and mortality and identified predictors in this subgroup. METHODS: A total of 4,984 subjects aged 60 years and older were identified from the National Health and Nutrition Examination Survey 1999-2004 linked to the National Death Index. LLM was defined using reduced appendicular lean mass (men < 19.75 kg; females < 15.02 kg). Obesity was defined using dual-energy x-ray absorptiometry body fat (males ≥ 25%; females ≥ 35%). LLM with obesity was defined using criteria for both LLM and obesity. Proportional hazard models determined mortality risk for LLM and LLM with obesity, separately (referent = no LLM and no LLM with obesity, respectively). RESULTS: Mean age was 71.1 ± 0.19 years (56.5% female). Median follow-up was 102 months (interquartile range: 78, 124) with 1,901 deaths (35.0%). Prevalence of LLM with obesity was 33.5% in females and 12.6% in males. In those with LLM, overall mortality risk was 1.49 (1.27, 1.73) in males and 1.19 (1.02, 1.40) in females. Mortality risk in LLM with obesity was 1.31 (1.11, 1.55) and 0.99 (0.85, 1.16) in males and females, respectively. Age, diabetes, history of stroke, congestive heart failure, cancer, and kidney disease were predictive of death. CONCLUSIONS: Risk of death is higher in subjects with LLM than with LLM and obesity. Having advanced age, diabetes, stroke, heart failure, cancer, and renal disease predict a worse prognosis in both classifications.

来源:J Gerontol A Biol Sci Med Sci,查看原文。版权归原作者所有。

引用

  1. Batsis JA, Mackenzie TA, Emeny RT, et al. Low Lean Mass With and Without Obesity, and Mortality: Results From the 1999-2004 National Health and Nutrition Examination Survey. J Gerontol A Biol Sci Med Sci. 2017. PMID: 28207042. doi:10.1093/gerona/glx002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。